If you enjoy this content, please share it with a colleague
IBM Corporation
Advance data analysis and collaboration. Facilitate clinical collaboration. Integrate disparate clinical, imaging, research, genomic and administrative data. Combine the benefits of data sharing with privacy protection. Deliver critical image and patient information, while improving the quality of patient care. IBM can help with data management solutions, security-rich storage and workstations offering outstanding visual performance.
RELATED CONTENT
January 21, 2022 — IBM and Francisco Partners, a leading global investment firm that specializes in partnering with ...
March 13, 2020 — IBM Watson Health and EBSCO Information Services (EBSCO) announced a strategic collaboration aimed ...
November 25, 2019 — Blackford, the centralized medical imaging platform, today announced that it had signed a multi-year ...
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer among women across the world. From our perspective, improved treatment options and earlier detection could have a positive impact on decreasing mortality, as this could offer more options for successful intervention and therapies when the disease is still in its early stages.
IBM Watson Health announced plans to make a 10-year, $50 million investment in research collaborations with two separate academic centers - Brigham and Women's Hospital, which is a teaching hospital of Harvard Medical School, and Vanderbilt University Medical Center - to advance the science of artificial intelligence (AI) and its application to major public health issues.
Guerbet LLC USA will feature its digital solutions including its ongoing collaboration with IBM Watson Health in medical imaging, at the 2018 annual meeting of the Radiological Society of North America (RSNA), Nov. 25-30 in Chicago.
Guerbet announced it has signed an exclusive joint development agreement with IBM Watson Health to develop an artificial intelligence (AI) software solution to support liver cancer diagnostics. The AI software will focus on utilizing computed tomography (CT) and magnetic resonance imaging (MRI), and care.
Elekta announced it is collaborating with IBM Watson Health to offer Watson for Oncology with Elekta’s cancer care solutions. Under the terms of a new agreement, Elekta will sell Watson for Oncology beginning in early 2018 as a clinical decision support (CDS) solution paired within Elekta’s digital cancer care solutions, including the Mosaiq oncology information system (OIS). Elekta intends to offer both solutions in most markets around the world including the U.S., Brazil, certain major European and Asian markets, as well as India and Australia.
Thirty radiologists from seven of Strategic Radiology’s 26 member practices will contribute to work undertaken by the Watson Health Medical Imaging Collaborative to advance natural language processing capabilities used in future cognitive medical imaging solutions. The radiologists will provide expert annotation of de-identified medical images that will be used by IBM to train Watson to recognize various medical imaging terms that would be found in a patient’s electronic medical record (EMR), as well as providing feedback on solution design.
Anne Le Grand, general manager of Watson Health Imaging, will explore the potential of cognitive imaging to aid radiologists in delivering high-quality, patient-centered care as this year’s Radiology Leadership Institute (RLI) Summit keynote speaker.